Issued Patents 2017
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9845301 | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors | Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert +6 more | 2017-12-19 |
| 9815832 | Azabenzimidazole compounds | Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward | 2017-11-14 |
| 9765073 | Cyclopropabenzofuranyl pyridopyrazinediones | Martin Youngjin Pettersson, Christopher William am Ende, Douglas Scott Johnson, Gregory Wayne Kauffman, Antonia Friederike Stepan | 2017-09-19 |
| 9751877 | Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders | Martin Youngjin Pettersson, Douglas Scott Johnson, Chakrapani Subramanyam, Christopher John O'Donnell, Christopher William am Ende +6 more | 2017-09-05 |
| 9751895 | N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides | Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Peter Mikochik +2 more | 2017-09-05 |
| 9695171 | 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors | Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Travis T. Wager, Lei Zhang +3 more | 2017-07-04 |
| 9642855 | Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors | Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Travis T. Wager, Lei Zhang +3 more | 2017-05-09 |
| 9611264 | N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides | Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Romelia del Carmen Salomon Ferrer | 2017-04-04 |
| 9598421 | Imidazopyridazine compounds | Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal, Simone Sciabola +2 more | 2017-03-21 |